Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

David Donabedian, GSK, on broadening networks and pinpointing therapeutic areas

  • Broadcast in Health



Follow This Show

If you liked this show, you should follow WBR.
Who are today’s partners of choice? Kelly Hushin, Online Content Manager for Worldwide Business Research, producers of BioNetwork East, asks this question to David Donabedian, Vice President of Strategic Alliances at the Centre of Excellence for External Drug Discovery group (or ceedd), at GSK.

BioNetwork is a three-day event for biotech and pharmaceutical companies that facilitates partnering conversations through one-to-one meetings and extended networking activities. David is a speaker at the 2011 event, where he'll talk further about how companies are broadening networks beyond big pharma to find partnerships and why certain therapeutic areas are receiving interest from partners. BioNetwork East 2011, will take place March 14 to 16 at the Edon-Roc Renaissance in Miami. You can visit the website to take a look at other speakers joining the program.